CM
GRNA

Crestline Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Crestline Management’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-51,684
Closed -$513K – 347
2021
Q4 		$513K Hold
51,684
– – 0.04% 153
2021
Q3 		$511K Hold
51,684
– – 0.05% 145
2021
Q2 		$507K Buy
51,684
+40,000
+342% +$392K 0.04% 111
2021
Q1 		$113K Buy
+11,684
New +$113K 0.01% 85